YAU-RCC Insights from AUA25 Annual Meeting: the crossfire of progress. Single-port vs. multi-port robotic surgery for kidney cancer [0.03%]
单孔与多孔机器人手术治疗肾癌：进步的碰撞
Riccardo Bertolo,Riccardo Campi,Riccardo Autorino et al.
Riccardo Bertolo et al.
Identifying the best candidates to prostatic artery embolization: indications and best practice across guidelines [0.03%]
前列腺动脉栓塞最佳适应症及指南共识要点
Giuseppe Pallotta,Maria C Sighinolfi,Francesco Pinto et al.
Giuseppe Pallotta et al.
From vintage to vanguard: has chemoablation's prime time finally arrived in bladder cancer treatment? [0.03%]
从经典到先锋：化疗消融在膀胱癌治疗中的黄金时期终于到来了吗？
Savio D Pandolfo,Maria Carmen Mir,Clara Cerrato et al.
Savio D Pandolfo et al.
Is it simpler with single-port?. A comparative analysis of single-port robot-assisted simple and radical nephrectomy in a tertiary referral center [0.03%]
单端口机器人辅助的简单与根治性肾切除术的比较分析——一项三级转诊中心的研究
Hakan B Haberal,Valerio Santarelli,Fabio M Valenzi et al.
Hakan B Haberal et al.
Background: Simple nephrectomy (SN), a procedure performed for benign kidney conditions, can be more challenging and complicated than radical nephrectomy (RN). With the widespread adoption of minimally invasive surgery, r...
Using cumulative summation analysis for the learning curve of robotic docking time in radical prostatectomy with the HUGO RAS System [0.03%]
累积和分析在使用HUGO机器人进行根治性前列腺切除术学习曲线中的应用——针对机器人对接时间的研究
Pierluigi P Russo,Mariachiara M Sighinolfi,Sara S Mastrovito et al.
Pierluigi P Russo et al.
Minimally invasive surgery like robotic surgery is known to yield better outcomes in terms of blood loss, blood transfusion, and length of stay, and robot-assisted radical prostatectomy provides a clear example compared to open surgery. It ...
Uro-vaxom (OM-89) for chronic UTI prevention: an updated meta-analysis, meta-regression and trial sequential analysis of recent clinical evidence [0.03%]
尿路疫苗(OM-89)预防慢性泌尿系感染的疗效和安全性的更新META分析、Meta回归及试验序贯分析
Breno C Porto,Artur S Almeida,Bruno D Terada et al.
Breno C Porto et al.
Introduction: Recurrent urinary tract infections (UTIs) are a common health issue that affects patients' quality of life and healthcare systems. To reduce antibiotic use, non-antimicrobial treatments, such as Uro-Vaxom (O...
Differences in efficacy and safety between HIF-PHIS and ESA/placebo in a sample of hemodialysis patients: a systematic review and meta-analysis [0.03%]
低氧诱导因子脯氨酰羟化酶抑制剂和促红细胞生成素/安慰剂在血液透析患者中有效性和安全性的差异：系统评价和 Meta 分析
Valeria Cernaro,Veronica Maressa,Guido Gembillo et al.
Valeria Cernaro et al.
Introduction: Treatment of anemia is one of the main goals of supportive care in patients on hemodialysis. In this context, the use of therapy with hypoxia inducible factor inhibitors (HIF-PHI) represents a further promis...
The impact of clinically insignificant residual fragments following endourological management of urolithiasis: a systematic review of complications and re-intervention rates [0.03%]
经尿道管理后临床意义不大的残留碎片的影响：并发症和再治疗率的系统评价
Alberto Quarà,Letizia M Jannello,Alejandra Bravo-Balado et al.
Alberto Quarà et al.
Introduction: Achieving stone-free status (SFS) is a key goal of endourological treatment, yet definitions of SFS and clinically insignificant residual fragments (CIRF) remain controversial. While CIRF is frequently defin...
The efficacy and safety of intravesical platelet-rich plasma injections into the bladder for the treatment of interstitial cystitis/bladder pain syndrome: a systematic review and meta-analysis [0.03%]
富血小板血浆膀胱内灌注治疗间质性膀胱炎/膀胱疼痛综合征的有效性和安全性的系统评价和meta分析
Hai-Rui Li,Ting Wang,Si-Hong Shen et al.
Hai-Rui Li et al.
Introduction: Interstitial cystitis/bladder pain syndrome is a chronic bladder condition with a rising incidence that significantly impacts the lives of millions worldwide. The lack of understanding regarding the pathophy...
RAASi, MRA and FGF-23 in CKD progression: the usual suspects? [0.03%]
慢性肾脏病进展过程中的肾素血管紧张素系统抑制剂、MRAs和FGF-23：是老嫌疑犯吗？
Giuseppe Cianciolo,Michele Provenzano,Lilio Hu et al.
Giuseppe Cianciolo et al.
Chronic kidney disease (CKD) affects almost 10% of the global population and is a significant health issue. The presence of CKD increases the risk of fatal and non-fatal cardiovascular events, overall mortality, and progression of renal dam...